top of page

Industry Projects

In collaboration with: 

CellTech - Stem Cell Technologies 

 

  • Identified potential partnerships, investors, and non-dilutive funding opportunities for CellTech to aid the progression and development of their FDA approval process.

  • Conducted KOL interviews and outreach to provide business development recommendations specific to CellTech’s business plan and goals.

CellTech is a small start-up biotechnology company in the veterinary medicine field seeking FDA approval for the clinical veterinary use of their allogeneic mesenchymal stem cell treatment.

image.png

Seqirus specializes in the development and manufacturing of vaccine solutions, primarily influenza and COVID-19 vaccines.

image.png
1729873114630.jfif
In collaboration with: 

CSL-Seqirus

 

  • Evaluated the current methods for influenza vaccine manufacturing to identify potential process improvements. 

  • Identified and evaluated the emerging methods for influenza vaccine manufacturing to provide a breakdown of the technologies that are going to drive influenza vaccine production in the next decade.

  • Analyzed the influenza vaccine market to determine what manufacturing and design technologies have the potential to thrive in the market in the future.

In collaboration with: 

Orsini

 

  • Conducted a SWOT analysis of Orsini’s current digital positioning to identify opportunities for improvement.

  • Analyzed competitor's digital positioning to help inform Orsini about the market and identify gaps.

  • Developed a digital marketing strategy to strengthen relationships with patients and biopharma partners.

​Orsini is an independent pharmaceutical company focused on treating rare diseases and complex therapy programs.

image.png
In collaboration with: 

RadPhysics

  • Assessed market potential and commercial viability of RadPhysics’ MERP® patient-safety platform.

  • Analyzed competitor landscape, customer needs, and regulatory factors influencing adoption.

  • Delivered strategic insights to support go-to-market planning and growth opportunities.

image.png

RadPhysics develops technology to improve patient safety in radiation oncology, primarily through its MERP® software platform for tracking, analyzing, and preventing treatment-related medical errors.

In collaboration with: 

Gilead

  • Assessed 40+ emerging technologies and evaluated maturity using a Technology Readiness Level (TRL) and risk framework for Gilead Sciences.

  • Identified high-impact opportunities in digital manufacturing (RFID, digital batch genealogy) and regulatory tech (AI-driven compliance tools).

  • Synthesized industry use cases and vendor landscapes to inform a relevance–impact prioritization model​

image.png

Gilead Sciences is a biopharmaceutical company focused on developing innovative therapies in virology, oncology, and inflammatory diseases.

bottom of page